Cargando…
Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report
Tocilizumab, an interleukin-6 receptor antagonist, has been used to treat critically ill patients with coronavirus disease-2019. We present the case of a previously immunocompetent man with coronavirus disease-2019 who developed invasive pulmonary aspergillosis after treatment with tocilizumab, illu...
Autores principales: | Witting, Celeste, Quaggin-Smith, Jessica, Mylvaganam, Ruben, Peigh, Graham, Angarone, Michael, Flaherty, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677089/ https://www.ncbi.nlm.nih.gov/pubmed/33388572 http://dx.doi.org/10.1016/j.diagmicrobio.2020.115272 |
Ejemplares similares
-
Dexamethasone/tocilizumab: Invasive pulmonary aspergillosis: case report
Publicado: (2021) -
Severe ARDS in a critically ill influenza patient with invasive pulmonary aspergillosis
por: Pietsch, Urs, et al.
Publicado: (2016) -
Tocilizumab: Invasive pulmonary aspergillosis following off-label use of tocilizumab for severe acute respiratory coronavirus-2 infection: case report
Publicado: (2021) -
Tocilizumab: Invasive pulmonary aspergillosis and Escherichia coli infection due to off-label use: case report
Publicado: (2020) -
Invasive Pulmonary Aspergillosis
por: Ledoux, Marie-Pierre, et al.
Publicado: (2023)